Outcome and data completeness
| Outcome completeness | Total | TAU | TRAK-ACL |
| Freq (%) | Freq (%) | Freq (%) | |
| KOOS | |||
| 0 | 51 (100) | 25 (100) | 26 (100) |
| 3 | 44 (86.27) | 19 (76) | 25 (96.15) |
| 6 | 40 (83.96) | 17 (68) | 23 (88.46) |
| No of items | 42 | 42 | 42 |
| Complete items | 42 (100) | 42 (100) | 42 (100) |
| Self-efficacy | |||
| 0 | 51 (100) | 25 (100) | 26 (100) |
| 3 | 44 (86.27) | 19 (76) | 25 (96.15) |
| 6 | 40 (78.43) | 17 (68) | 23 (88.46) |
| No of items | 6 | 6 | 6 |
| Complete items | 6 (100) | 6 (100) | 6 (100) |
| CSRI | |||
| 0 | 51 (100) | 25 (100) | 26 (100) |
| 3 | 44 (86.27) | 19 (76) | 25 (96.15) |
| 6 | 40 (78.43) | 17 (68) | 23 (88.46) |
| No of items | 114 | 114 | 114 |
| Complete items | 64 (54.38) | 79 (69.29) | 102 (89.47) |
| WPAI | |||
| 0 | 51 (100) | 25 (100) | 26 (100) |
| 3 | 44 (86.27) | 19 (76) | 25 (96.15) |
| 6 | 40 (78.43) | 17 (68) | 23 (31.08) |
| No of items | 6 | 6 | 6 |
| Complete items | 6 (100) | 6 (100) | 6 (100) |
| EQ-5D-5L | |||
| 0 | 51 (100) | 25 (100) | 26 (100) |
| 3 | 44 (86.27) | 19 (76) | 25 (96.15) |
| 6 | 40 (78.43) | 17 (68) | 23 (31.08) |
| No of items | 5 | 5 | 5 |
| Complete items | 5 (100) | 5 (100) | 5 (100) |
| Strength outcome | 3 months | 6 months | |
| Leg extension | |||
| Total in study at site 1 | 37 | 33 | |
| Yes | 33 (89.18) | 30 (90.90) | |
| No | 4 (10.81) | 3 (9.09) | |
| Reason | Pain or DNA | Pain or DNA |
| Physiotherapy appointments | n=51, mean (SD) | ||
| Total physiotherapy appointments per person | 16.01 (5.04) |
EQ-5D-5L, an instrument for measuring generic health related quality of life
CSRI, Client Services Receipt Inventory; KOOS, Knee Injury and Osteoarthritis Outcome Score; TAU, treatment as usual; TRAK—ACL, taxonomy for the rehabilitation of knee conditions—ACL; WPAI, work productivity and impairment.